Answers are grounded in this paper and cite their sources.
Our study shows that looking for a combination of paroxysmal events, hyperkinesia, neuropsychiatric symptoms, and cognitive impairment and evaluating the CADD score and variant location can help identify an ATP1A3-related condition, rather than applying diagnostic criteria alone.
No takes yet. Share an insight, caveat, or question.
Vezyroglou et al. (2022) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: